These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8853513)
21. [Effect of diazepam on delayed nausea and vomiting caused by anticancer agents]. Tong FZ; Zhang JQ; Qiao XM; Mao YC; Meng FY; Liu HJ; Hui S; Zhu FX; Shu W; Hong J Gan To Kagaku Ryoho; 1998 Feb; 25(3):391-5. PubMed ID: 9492833 [TBL] [Abstract][Full Text] [Related]
22. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy. Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706 [TBL] [Abstract][Full Text] [Related]
23. Clinical practice guidelines on antiemetics in oncology. Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087 [TBL] [Abstract][Full Text] [Related]
24. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant. Grote T; Hajdenberg J; Cartmell A; Ferguson S; Ginkel A; Charu V J Support Oncol; 2006 Sep; 4(8):403-8. PubMed ID: 17004515 [TBL] [Abstract][Full Text] [Related]
25. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial. Lajolo PP; de Camargo B; del Giglio A Am J Clin Oncol; 2009 Feb; 32(1):23-6. PubMed ID: 19194119 [TBL] [Abstract][Full Text] [Related]
26. Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing? Grunberg SM J Support Oncol; 2004; 2(1 Suppl 1):1-10, inside back cover; quiz 11. PubMed ID: 16117016 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents]. Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945 [TBL] [Abstract][Full Text] [Related]
28. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. Navari RM Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308 [TBL] [Abstract][Full Text] [Related]
29. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy. Decker GM; DeMeyer ES; Kisko DL J Support Oncol; 2006 Jan; 4(1):35-41, 52. PubMed ID: 16444851 [TBL] [Abstract][Full Text] [Related]
30. [Effect of steroid on antiemetic for side effect of anticancer chemotherapy]. Nakamura Y; Momokawa K; Sasaki T; Sakayauchi T; Watanabe T; Mikami T; Matsumoto T Gan To Kagaku Ryoho; 2005 Mar; 32(3):401-4. PubMed ID: 15791827 [TBL] [Abstract][Full Text] [Related]
31. Relieving nausea and vomiting in patients with cancer: a treatment algorithm. Johnson MH; Moroney CE; Gay CF Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907 [TBL] [Abstract][Full Text] [Related]
32. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F; Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346 [TBL] [Abstract][Full Text] [Related]
33. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients? de Wit R; Aapro M; Blower PR Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653 [TBL] [Abstract][Full Text] [Related]
34. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy. Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140 [TBL] [Abstract][Full Text] [Related]
35. Optimising antiemetic therapy: what are the problems and how can they be overcome? Aapro M Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889 [TBL] [Abstract][Full Text] [Related]
36. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. Slatkin NE J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383 [TBL] [Abstract][Full Text] [Related]
37. Nausea and vomiting and cancer patients' quality of life: a discussion of Professor Selby's paper. Lindley CM; Hirsch JD Br J Cancer Suppl; 1992 Dec; 19():S26-9. PubMed ID: 1467197 [TBL] [Abstract][Full Text] [Related]
38. [Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer]. Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J Gan To Kagaku Ryoho; 1997 Jul; 24(9):1095-101. PubMed ID: 9239162 [TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-induced nausea and vomiting. Lohr L Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612 [TBL] [Abstract][Full Text] [Related]
40. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives. Schwartzberg LS J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]